Elisa Nuti

Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: Solution and X-ray crystallographic studies

Murat Bozdağ, Marta Ferraroni, Elisa Nuti et al. · Bioorganic & Medicinal Chemistry · 2013 · 109 citations · Full text

X-ray Crystallographic Studies, Medicinal Chemistry, Ring Approaches +9

New N-arylsulfonyl-N-alkoxyaminoacetohydroxamic acids as selective inhibitors of gelatinase A (MMP-2)

Armando Rossello, Elisa Nuti, Elisabetta Orlandini et al. · Bioorganic & Medicinal Chemistry · 2004 · 84 citations

Medicinal Chemistry, Biochemistry, Natural Sciences +7

Vascular ADAM17 as a Novel Therapeutic Target in Mediating Cardiovascular Hypertrophy and Perivascular Fibrosis Induced by Angiotensin II

Takehiko Takayanagi, Steven J. Forrester, Tatsuo Kawai et al. · Hypertension · 2016 · 79 citations · Full text

Amber force field implementation, molecular modelling study, synthesis and MMP-1/MMP-2 inhibition profile of (R)- and (S)-N-hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamides

Tiziano Tuccinardi, Adriano Martinelli, Elisa Nuti et al. · Bioorganic & Medicinal Chemistry · 2006 · 73 citations

Molecular Modelling Study, Combinatorial Chemistry, Medicinal Chemistry +13

<i>N</i>-<i>O</i>-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity

Elisa Nuti, Anna Rita Cantelmo, Cristina Gallo et al. · Journal of Medicinal Chemistry · 2015 · 71 citations · Full text

Pharmacotherapy, Chemical Biology, Pharmaceutical Chemistry +24